Full Text (PDF)
Indian Journal of Cancer Education and Research 11(1):p 45-46, January-June 2023. | DOI: https://doi.org/10.21088/ijcer.2321.9815.11123.5
Case Report
Adenocarcinoma Prostate Converted Into Neuroendocrine Tumor
Sindhuja Ramachandran, Shyamji Rawat, Mishi Tiwari, Rahul R Verma, Ekta Kotwal, Gaurav Hindoliya
Author Information
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Indian Journal of Cancer Education and Research 11(1):p 45-46, January-June 2023. | DOI: https://doi.org/10.21088/ijcer.2321.9815.11123.5
How Cite This Article:
Rawat S, Sindhuja R, Tiwari M, et al. Adenocarcinoma prostate converted into neuroendocrine tumor. Indian J Canc Educ Res. 2023;11(1):45-46.Timeline
Received : March 17, 2023
Accepted : April 05, 2023
Published : May 30, 2023
Abstract
Prostate cancer is the second most1 common malignancy diagnosed in males worldwide with an incidence of 5.5% in Indian males.2,3 Most common histopathology is adenocarcinoma constitute 93% a tumor type driven by androgen and increased prostate specifc antigen (PSA). Rarely patient may present with de novo small cell carcinoma of prostate, a poorly differentiated neuroendocrine carcinoma. But patient diagnosed as adenocarcinoma and conversion into Neuroendocrine tumor is extremely rare phenomenon in prostate cancer.
References
- 1. GLOBOCON
- 2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831497/
- 3. h t t p s : / / w w w . r e s e a r c h g a t e . n e t /publication/271332914_Epidemiology_of_
- 4. h t t p s : / / e n . w i k i p e d i a . o r g / w i k i /Histopathologic_diagnosis_of_prostate_cancer.
- 5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803064/#R7.
- 6. Aggarwal R, Huang J, Alumkal JJ, et al. Clinical and genomic characterization of treatmentemergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study. J ClinOncol 2018;36(24):2492–503. [PMC free article] [PubMed] [Google Scholar]
- 7. Abida W, Cyrta J, Heller G, et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl AcadSci U S A 2019;116(23):11428–36. [PMC free article] [PubMed] [Google Scholar]
- 8. Bluemn EG, Coleman IM, Lucas JM, et al. Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling. Cancer Cell 2017;32(4):474–89. E6. [PMC free article] [PubMed] [Google Scholar]
- 9. Beltran H, Prandi D, Mosquera JM, et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med 2016;22(3):298–305. [PMC free article] [PubMed] [Google Scholar]
- 10. Beltran H, Tagawa ST, Park K, et al. Challenges in recognizing treatment-related neuroendocrine prostate cancer. J ClinOncol 2012;30:e386–9. [PubMed] [Google Scholar]
- 11. Hoefnagel LD, van de Vijver MJ, van Slooten HJ, Wesseling P, Wesseling J, Westenend PJ, Bart J, Seldenrijk CA, Nagtegaal ID, Oudejans J, van der Valk P, van der Groep P, de Vries EG, van der Wall E, van Diest PJ. Receptor conversion in distant breast cancer metastases. Breast Cancer Res. 2010;12(5):R75. Doi: 10.1186/bcr2645. Epub 2010 Sep 23. PMID: 20863372; PMCID: PMC3096964.
- 12. Hiroaki Iwamoto, Ryunosuke Nakagawa, Tomoyuki Makino, Suguru Kadomoto, Hiroshi Yaegashi, Takahiro Nohara, Kazuyoshi Shigehara, Kouji Izumi, Yoshifumi Kadono And Atsushi Mizokami Anticancer Research April 2022, 42 (4) 2167-2176; DOI: https://doi.org/10.21873/ anticanres.15699.
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
Whether all authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Rawat S, Sindhuja R, Tiwari M, et al. Adenocarcinoma prostate converted into neuroendocrine tumor. Indian J Canc Educ Res. 2023;11(1):45-46.
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| March 17, 2023 | April 05, 2023 | May 30, 2023 |
DOI: https://doi.org/10.21088/ijcer.2321.9815.11123.5
Keywords
Neuroendocrine prostateCa prostate convertedSearch for Similar Articles
Similar Articles
- Unusual Presentation of Solitary Metastasis to the Right Metacarpal Bone in Rena...
- Technical Feasibility and Planning Challenges of Delivering Total Body Irradiat...
- Excellent Response Rates with Bortezomib - Cyclophosphamide – Dexamethasone (VCD...
- Optimizing Postoperative Radiation Therapy in Ewing’s Sarcoma with Lung Metasta...
- Current Therapeutic Strategies Targeting Tyrosine Kinase Receptor in Colon Canc...
Article Level Metrics
Last UpdatedFriday 31 July 2026, 15:24:29 (IST)
1318
Accesses
18
266
00
Citations
NA
NA
NA
Download citation
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | March 17, 2023 |
| Accepted | April 05, 2023 |
| Published | May 30, 2023 |
licence
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
